Toronto-based psychedelic therapy company Reunion Neuroscience has partnered with the Seleni Institute, a nonprofit organization, to sponsor maternal mental health training courses.
This collaboration aims to provide healthcare professionals access to the Seleni Institute's evidence-based training on maternal mental health conditions, including perinatal mood and anxiety disorders and postpartum depression. Through this sponsorship, Reunion intends to enhance the diagnosis and treatment of maternal mental health disorders.
Analyst QuickTake: This partnership aligns with Reunion's ongoing Phase II RECONNECT trial, which evaluates RE104 for treating postpartum depression. In April 2024 , the company also partnered with Fluence to receive psychedelic training support for its Phase II clinical trial.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.